Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Disorders01:29

Bone Disorders

5.7K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.7K
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

10.3K
Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
10.3K
Bone Formation by Intramembranous Ossification01:29

Bone Formation by Intramembranous Ossification

12.1K
Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
12.1K
What is the Skeletal System?01:02

What is the Skeletal System?

58.1K
Overview
58.1K
Bone Remodeling01:40

Bone Remodeling

40.7K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.7K
Spongy Bone01:09

Spongy Bone

8.7K
All bones comprise an outer layer of compact bone, and an interior made up of spongy bone tissue, also called cancellous or trabecular bone. In long bones, spongy bone tissue is mainly found in the interior of the epiphyses (broad ends of the bone).
Spongy bone is more porous, and less dense compared to compact bone. It is composed of concentric lamellae that are arranged irregularly to form the trabecular network. In some bones, the spaces between trabeculae contain red marrow, where...
8.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Model-based somapacitan dosing and IGF-I response in children born SGA or with ISS, Noonan or Turner syndromes.

Journal of the Endocrine Society·2026
Same author

Continuous subcutaneous recombinant PTH(1-34) infusion improves serum calcium and phosphate homeostasis in children with autosomal dominant hypocalcemia type 1 refractory to standard-of-care treatment.

European journal of endocrinology·2026
Same author

Excluding children: What "no-kids zones" reveal about our collective future.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2026
Same author

Safety, tolerability, pharmacokinetics, and efficacy of burosumab in infants with X-linked hypophosphataemia: an open-label, multicentre, non-randomised study.

The lancet. Diabetes & endocrinology·2026
Same author

Risk of bone overstimulation in long-term PTH(1-34) therapy for hypoparathyroidism.

European journal of endocrinology·2026
Same author

Impact of idiopathic short stature on children's well-being: a nationwide study of short Danish children.

Journal of the Endocrine Society·2026
Same journal

[18F]F-DOPA and [18F]F-FDG PET/CT for staging advanced medullary thyroid cancer.

Annales d'endocrinologie·2026
Same journal

Corrigendum to 'Pink adipose tissue: A paradigm of adipose tissue plasticity' [Ann. Endocrinol. 85 (2004) 248-51].

Annales d'endocrinologie·2026
Same journal

Intraoperative location of parathyroid glands during total thyroidectomy: a systematic review of the literature according to the PRISMA method.

Annales d'endocrinologie·2026
Same journal

Clinical and genetic diagnosis of PHP1A associated with hypogonadism in a young male: A case report.

Annales d'endocrinologie·2026
Same journal

Autoimmune features in acquired generalized lipodystrophy and anti-perilipin 1 antibodies: A case report.

Annales d'endocrinologie·2026
Same journal

The diagnostic challenge of occult glucocorticoid exposure causing Cushing's syndrome.

Annales d'endocrinologie·2026
See all related articles

Related Experiment Video

Updated: Mar 2, 2026

Tricolor Transgenic Murine Model for Studying Growth Plate Injury
07:58

Tricolor Transgenic Murine Model for Studying Growth Plate Injury

Published on: September 6, 2024

1.2K

Bone dysplasia.

Agnès Linglart1, Valérie Merzoug2, Anne-Sophie Lambert1

  • 1Service d'endocrinologie et diabétologie pour enfants, centre de référence des maladies rares du métabolisme du calcium et du phosphate, plateforme d'expertise Paris Sud des maladies rares, filière OSCAR, hôpital Bicêtre Paris Sud, AP-HP, 94270 Le Kremlin-Bicêtre, France.

Annales D'Endocrinologie
|May 13, 2017
PubMed
Summary
This summary is machine-generated.

Bone dysplasia, a group of rare diseases, often causes short stature. Diagnosis involves physical, radiographic, and genetic assessments for effective multidisciplinary care.

Keywords:
Bone dysplasiaCartilage de croissanceDysplasie osseuseGrowth hormoneGrowth platesHormone de croissancePetite tailleShort stature

More Related Videos

Culture of Murine Embryonic Metatarsals: A Physiological Model of Endochondral Ossification
07:23

Culture of Murine Embryonic Metatarsals: A Physiological Model of Endochondral Ossification

Published on: December 3, 2016

12.5K
Culturing and Measuring Fetal and Newborn Murine Long Bones
06:58

Culturing and Measuring Fetal and Newborn Murine Long Bones

Published on: April 26, 2019

8.7K

Related Experiment Videos

Last Updated: Mar 2, 2026

Tricolor Transgenic Murine Model for Studying Growth Plate Injury
07:58

Tricolor Transgenic Murine Model for Studying Growth Plate Injury

Published on: September 6, 2024

1.2K
Culture of Murine Embryonic Metatarsals: A Physiological Model of Endochondral Ossification
07:23

Culture of Murine Embryonic Metatarsals: A Physiological Model of Endochondral Ossification

Published on: December 3, 2016

12.5K
Culturing and Measuring Fetal and Newborn Murine Long Bones
06:58

Culturing and Measuring Fetal and Newborn Murine Long Bones

Published on: April 26, 2019

8.7K

Area of Science:

  • Pediatric Endocrinology
  • Genetics
  • Radiology

Background:

  • Bone dysplasia comprises 436 rare diseases, frequently manifesting as short stature or reduced growth velocity.
  • These conditions often involve skeletal abnormalities and can affect multiple organs, necessitating comprehensive care.

Purpose of the Study:

  • To outline the diagnostic approach for short stature in skeletal dysplasia.
  • To emphasize the multidisciplinary management required for affected individuals.

Main Methods:

  • Diagnosis integrates physical examination (disproportionate features, limb length, build).
  • Radiographic analysis assesses bone mineralization, maturation, and morphology.
  • Genetic characterization is utilized when feasible.

Main Results:

  • Short stature in bone dysplasia is diagnosed through a combination of clinical, radiographic, and genetic findings.
  • Multidisciplinary follow-up is crucial due to the systemic impact of these conditions.

Conclusions:

  • Accurate diagnosis of bone dysplasia is essential for appropriate management.
  • Pediatric endocrinologists play a key role in assessing growth potential and managing psychosocial aspects of short stature.